Activist Cannell Capital Loves Micro-Caps

Cannell has held a stake in Intralinks Holdings Inc (NYSE:IL) since the third quarter of 2012 and during the second quarter the firm added some 7,500 shares to it, taking the total amount to 1.96 million shares valued at $23.34 million. The holding represents 7.63% of the firm’s portfolio and 3.45% of the company’s outstanding stock. Intralinks Holdings Inc (NYSE:IL) is in the business of providing technology and services that allow sellers to give their prospective buyers access to their financial information. The company claims that the global number of deals on its platform will increase by 11% this year compared to last year. If realized, this would set a new record for the number of deals in a given year and also result in more top line growth opportunities for Intralinks. Although down by 3.45% so far this year, Intralinks Holdings Inc (NYSE:IL)’s stock price has appreciated by more than 36% over the last 12 months. Jim Simons‘ Renaissance Technologies increased its Intralinks Holdings Inc (NYSE:IL)  holding by 22% during the June quarter to 2.56 million shares valued at $30.46 million.

Lastly, the fund’s position in BioTelemetry, Inc. (NASDAQ:BEAT) received a 4% bump to 1.53 million shares valued at $14.38 million. The holding amasses about 5.72% of the company’s outstanding shares. The $315.12 million provider of cardiac monitoring services delivered an EPS of $0.12 for the second quarter, beating estimates by $0.03. Revenues of $44.81 million, however, came in lighter than the $45.75 million expected. BioTelemetry, Inc. (NASDAQ:BEAT)’s stock price has surged by nearly 16% so far this year, compared to the 9.17% rise for the Diagnostics & Research industry. Among other shareholders of the company that we track is Craig A. Drill‘s Craig Drill Capital, which trimmed its holding in the company by 1% during the June quarter to 1.01 million shares valued at $17.69 million.

Disclosure: None